Cardiac function evaluation in children with spinal muscular atrophy: A case–control study
Authors:
- 1 January 2024
- journal article
- research article
- Published by Wiley in Pediatrics International
- Vol. 66 (1) , e15769
Abstract
Background: Spinal muscular atrophy (SMA) is an autosomal recessive disorder characterized by degeneration of lower motor neurons, resulting in progressive muscle weakness and atrophy. However, little is known regarding the cardiac function of children with SMA. Methods: We recruited SMA patients younger than 18 years of age from January 1, 2022, to April 1, 2022, in the First Affiliated Hospital of Sun Yat‐sen University. All patients underwent a comprehensive cardiac evaluation before treatment, including history taking, physical examination, blood tests of cardiac biomarkers, assessment of echocardiography and electrocardiogram. Age/gender‐matched healthy volunteers were recruited as controls. Results: A total of 36 SMA patients (26 with SMA type 2 and 10 with SMA type 3) and 40 controls were enrolled in the study. No patient was clinically diagnosed with heart failure. Blood tests showed elevated values of creatine kinase isoenzyme M and isoenzyme B (CK‐MB) mass and high‐sensitivity cardiac troponin T (hs‐cTnT) in spinal muscular atrophy (SMA) patients. Regarding echocardiographic parameters, SMA children were detected with lower global left and right ventricular longitudinal strain, abnormal diastolic filling velocities of trans‐mitral and trans‐tricuspid flow. The results revealed no clinical heart dysfunction in SMA patients, but subclinical ventricular dysfunction was seen in SMA children including the diastolic function and myocardial performance. Some patients presented with elevated heart rate and abnormal echogenicity of aortic valve or wall. Among these SMA patients, seven patients (19.4%) had scoliosis. The Cobb's angles showed a significant negative correlation with LVEDd/BSA, but no correlation with other parameters, suggesting that mild scoliosis did not lead to significant cardiac dysfunction. Conclusions: Our findings warrant increased attention to the cardiac status and highlight the need to investigate cardiac interventions in SMA children.Keywords
Funding Information
- National Natural Science Foundation of China (81900350)
This publication has 18 references indexed in Scilit:
- Spinal Muscular Atrophy: In the Challenge Lies a SolutionTrends in Neurosciences, 2021
- Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatmentAnnals of Clinical and Translational Neurology, 2021
- NT‐proBNP Qualifies as a Surrogate for Clinical End Points in Heart FailureClinical Pharmacology & Therapeutics, 2021
- Cardiac findings in pediatric patients with spinal muscular atrophy types 2 and 3Muscle & Nerve, 2020
- Overturning the Paradigm of Spinal Muscular Atrophy as Just a Motor Neuron DiseasePediatric Neurology, 2020
- A Test in Context: Myocardial Strain Measured by Speckle-Tracking EchocardiographyJACC, 2017
- Ventricular and atrial mechanics and their interaction in patients with congenital scoliosis without clinical heart failureCardiology in the Young, 2014
- Pre-Clinical Diastolic DysfunctionJACC, 2014
- Digital necroses and vascular thrombosis in severe spinal muscular atrophyMuscle & Nerve, 2010
- Vascular Perfusion Abnormalities in Infants with Spinal Muscular AtrophyThe Journal of Pediatrics, 2009